Oncology CME

Credits: 1.00 CME / CNE
Penn State College of Medicine
Driving Change in Multiple Myeloma: Updates on Novel Agent Classes and Next-Generation Therapeutics
Robert Z. Orlowski, MD, PhD
8 August, 2019
Credits: 0.75 CME / MOC / CNE
Medical Learning Institute, Inc.
Expanding Treatment Choices in Mesothelioma: Exploring the Promise of Tumor Treating Fields and Novel Systemic Approaches to Optimize Patient Outcomes
Charles B. Simone, MD, FACRO
29 July, 2019
Credits: 1.50 CME
Medical Learning Institute, Inc.
Candid Conversations About NSCLC—Live From Chicago: Navigating Immunotherapies and Combinations in the Search for the Best Strategy for Each Patient
Benjamin Levy, MD
25 July, 2019
Credits: 2.00 CME / MOC / CNE
Medical Learning Institute, Inc.
Stories From the Pancreatic Cancer CaseBook: Taking the Road to Improved Outcomes With Modern Therapeutic Concepts and Innovative Treatments
Johanna C. Bendell, MD
22 July, 2019
Credits: 2.00 CME / MOC
Medical Learning Institute, Inc.
‘How I Think, How I Treat’—Embarking on a New Treatment Era in Hepatocellular Carcinoma: A Personal Take on Integrating Recent Evidence Into the Continuum of Care for Patients With HCC
Ghassan Abou-Alfa, MD, MBA
19 July, 2019
Credits: 0.50 CME
Penn State College of Medicine
Taking a New Look at Mantle Cell Lymphoma in the Era of Novel Agent Classes: From Innovative Concepts to Practical Applications of Evidence
John Allan, MD
17 July, 2019
Credits: 1.50 CME
Penn State College of Medicine
New Concepts in Prostate Cancer Care: What Oncologists Need to Know to Optimize Patient Outcomes
Robert Dreicer, MD, MS, MACP, FASCO
16 July, 2019
Credits: 2.00 CME
Penn State College of Medicine
A MasterClass on Innovative Therapy in B-Cell Lymphoma: Evidence, Clinical Guidance, and Insights on the Future of Patient Care
Nathan H. Fowler, MD
3 July, 2019
Credits: 1.50 CME / MOC
Medical Learning Institute, Inc.
Redefining the Management of Advanced RCC: An Expert Tumor Board on Rational Selection, Sequencing, and Combination of Targeted Agents and Immunotherapy
David F. McDermott, MD
3 July, 2019
Credits: 1.50 CME / MOC / CNE
Medical Learning Institute, Inc.
Mapping Progress With Immune Checkpoint Inhibitors in Head and Neck Cancer: Expert Views on Immunotherapy as a Component of Multimodal Care
Ezra Cohen, MD, FRCPSC, FASCO
2 July, 2019
Credits: 1.00 CME / CNE / CPE
Medical Learning Institute, Inc.
Beyond the Basics of Immuno-Oncology: Navigating Clinical Challenges to Maximize the Benefits and Minimize the Risks of Cancer Immunotherapies
Evan J. Lipson, MD
26 June, 2019
Credits: 0.50 CME / MOC / CNE / CPE
Medical Learning Institute, Inc.
Taking a New Look at Cancer-Associated Venous Thromboembolism: How Is Emerging Evidence Influencing Guidelines & Practice?
Robert D. McBane, MD
25 June, 2019
Credits: 1.50 CME / MOC
Medical Learning Institute, Inc.
Changing the Treatment Story in Myelofibrosis: New Science and More Choices for Challenging Cases in the JAK Inhibitor Era
Professor Claire Harrison, MD
25 June, 2019
Credits: 1.00 CME / CNE / CPE
Penn State College of Medicine / Medical Learning Institute, Inc.
The Emergence of Oral Therapy as a Pillar of Care in B-Cell Lymphoma: Insights and Expert Opinions From the Hematology-Oncology Team
Nathan H. Fowler, MD
21 June, 2019
Credits: 1.50 CME / MOC / CNE
Medical Learning Institute, Inc.
The Expanding Role of Immunotherapy in Locally Advanced and Earlier Stages of Lung Cancer: Rationale, Current Evidence, Key Trials, and Implications for Thoracic Surgeons
Jessica Donington, MD
17 June, 2019
Credits: 1.50 CME
Penn State College of Medicine
Advancing the Management of Urothelial Cancer With Immuno-Oncology and Targeted Approaches: Key Concepts for Urology Professionals on the Front Lines of Care
Neal D. Shore, MD, FACS
6 June, 2019
Credits: 1.25 CME / MOC / CNE
Medical Learning Institute, Inc.
On the Cusp of the Era of Immuno-Oncology in Triple-Negative Breast Cancer: Rational Strategies to Make the Most of Immunotherapies and Other Effective Treatment Modalities Throughout the Disease Continuum
Elizabeth A. Mittendorf, MD, PhD
3 June, 2019
Credits: 1.00 CME / MOC / CNE
Medical Learning Institute, Inc.
A New Era Has Begun in the Treatment of SCLC: Navigating Novel Therapeutic Options and Strategies for Improving Patient Outcomes
Stephen V. Liu, MD
29 May, 2019
Credits: 1.50 CNE
Medical Learning Institute, Inc.
Navigating the CAR-T Cell Therapy Landscape in Hematologic Malignancies: Science and Practical Issues in Nursing Care
Susan Blumel, RN, BSN
24 May, 2019
Credits: 1.50 CNE
Medical Learning Institute, Inc.
Clinical Advances in Pancreatic Cancer: The Oncology Nurse as a Leader and Advocate for Patients in a Changing Therapeutic Landscape
Gayle Jameson, MSN, ACNP-BC, AOCN
22 May, 2019
Credits: 1.50 CME / CNE
Penn State College of Medicine / Medical Learning Institute, Inc.
An Oncology Nurse MasterClass on Oral Therapy in B-Cell Malignancies: Insights on Evidence, Practical Strategies, and the Nurse-Patient Partnership
Barbara Barnes Rogers, CRNP, MN, AOCN, ANP-BC
22 May, 2019
Credits: 1.50 CNE
Medical Learning Institute, Inc.
Realizing the Promise of PARP Inhibitors in Solid Tumor Therapy: Guiding Oncology Nurses on the Advances and Challenges
Kimberly Halla, MSN, FNP-C
21 May, 2019
Credits: 1.50 CNE / CE
Medical Learning Institute, Inc.
Taking Aim at B-Cell Malignancies With BTK Inhibitors: Oncology Nurse Perspectives and Insights on Clinical Care
Mollie Moran, APRN-CNP, AOCNP
16 May, 2019
Credits: 1.50 CME / MOC / CNE
Medical Learning Institute, Inc.
The Present and Future of Immunotherapy as a Key Component of the Treatment Arsenal for Locally Advanced & Earlier Stages of Lung Cancer
Leora Horn, MD, MSc, FRCPC
9 May, 2019
Credits: 1.50 CME / CNE
Penn State College of Medicine
BTK Inhibition as an Anti-Cancer Strategy: Exploring a Model for Modern Targeted Therapy in Hematologic Malignancies and Beyond
John C. Byrd, MD
6 May, 2019
Credits: 1.00 CME
Medical Learning Institute, Inc.
Rethinking Care in Hepatocellular Carcinoma Amid Expanding Treatment Options: An Interdisciplinary Discussion
Richard S. Finn, MD / Laura M. Kulik, MD
6 May, 2019
Credits: 1.50 CME / MOC / CC
Medical Learning Institute, Inc.
Keeping Up With Advances in Cancer Immunotherapy and Biomarker Testing: Implications for Pathologists at the Forefront of the Emerging Precision Immuno-Oncology Era
Robert Anders, MD, PhD
1 May, 2019
Credits: 1.00 CME / CNE
Penn State College of Medicine / Medical Learning Institute, Inc.
Oncology Nurse Insights Into New Agent Classes and Research in B-Cell Lymphoma: Practical Issues and Evidence for the Front-Lines of Care
Amy Goodrich, NP
30 April, 2019
Credits: 1.50 CME / MOC / CNE
Medical Learning Institute, Inc.
New Frontiers in Precision Immuno-Oncology: Leveraging Biomarkers to Refine and Expand the Use of Cancer Immunotherapies and Combinations
Justin Gainor, MD
26 April, 2019
Credits: 1.00 CME
Medical Learning Institute, Inc.
Progress and Promise With Immunotherapy in Resectable Melanoma: Exploring New Evidence and Practical Issues With Checkpoint Inhibitors as Adjuvant Therapy
Jason J. Luke, MD, FACP / Jennifer Wargo, MD, MMSc
25 April, 2019

Pages